Related Experiment Video

Updated: May 30, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Specific and prolonged proteasome inhibition dictates apoptosis induction by marizomib and its analogs

Claudia P Miller1, Christa A Manton, Randal Hale

  • 1Department of Pediatrics Research, Children's Cancer Hospital at M.D. Anderson, University of Texas M.D. Anderson Cancer Center, Houston, United States.

Chemico-Biological Interactions
|August 26, 2011
PubMed

Insights

Marizomib, a proteasome inhibitor, triggers leukemia cell death through sustained inhibition of proteasome activity. This mechanism is crucial for developing more effective anti-proteasome therapies against leukemia.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Marizomib (NPI-0052) is a natural irreversible proteasome inhibitor.
  • Proteasome inhibitors are investigated for leukemia treatment.
  • Apoptosis induction is a key mechanism in cancer therapy.

Purpose of the Study:

  • To elucidate the link between irreversible proteasome inhibition and leukemia cell death.
  • To investigate the role of sustained proteasome inhibition in apoptosis.
  • To compare the effects of reversible and irreversible marizomib analogs.

Main Methods:

  • Utilized marizomib analogs with varying inhibition properties (reversible/irreversible).
  • Assessed apoptosis induction in leukemia cells.
  • Analyzed proteasome activity and caspase-8/ROS pathways.

Main Results:

  • Sustained inhibition of at least two proteasome activities is critical for apoptosis induction.
  • Marizomib induces apoptosis via caspase-8 and reactive oxygen species (ROS) dependent pathways.
  • Irreversible inhibition is key for potent apoptosis induction.

Conclusions:

  • Sustained, multi-proteasome activity inhibition is essential for effective anti-leukemia therapy.
  • Marizomib's mechanism provides a basis for novel anti-proteasome drug development.
  • Understanding inhibition kinetics is vital for optimizing proteasome inhibitor efficacy.

More Related Videos

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.